Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Pulmonx Corp. (LUNG) PT Raised to $12 at Citi, Downgraded From Buy-High Risk to Buy
February 23, 2023 5:50 AM ESTCiti analyst Joanne Wuensch raised the price target on Pulmonx Corp. (NASDAQ: LUNG) to $12.00 (from $10.00) while maintaining a Buy rating.
The analyst comments "Pulmonxs 4Q22 sales were better than expected, delivering $15.4M (up 18.4% y/y ex-fx), ahead of consensuss... More
